21h
Zacks Investment Research on MSNMerck (MRK) Is Considered a Good Investment by Brokers: Is That True?When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...
White House reports declining inflation and job market gains under Trump's policies, with added border security success.
The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...
Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...
Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...
The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...
A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil.
Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...
Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results